|
| 10604382 | Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum. | J Urol | 2000 |
| 10379751 | Have complication rates decreased after treatment for localized prostate cancer? | J Urol | 1999 |
| 10411025 | Prostate specific antigen: a decade of discovery--what we have learned and where we are going. | J Urol | 1999 |
| 9697777 | Understanding artificial neural networks and exploring their potential applications for the practicing urologist. | Urology | 1998 |
| 9474183 | A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. | J Urol | 1998 |
| 9663202 | Transurethral needle ablation of the prostate: a minimally invasive treatment for symptomatic benign prostatic hyperplasia. | Mayo Clin Proc | 1998 |
| 9610564 | Percent free prostate-specific antigen: the next frontier in prostate-specific antigen testing. | Urology | 1998 |
| 9609620 | Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist. | Urology | 1998 |
| 9511773 | Benign prostatic hyperplasia: use of drug therapy in primary care. | Geriatrics | 1998 |
| 9510346 | Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. | Urology | 1998 |
| 9554360 | A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. | J Urol | 1998 |
| 9586598 | Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. Finasteride PSA Study Group. | Urology | 1998 |
| 9674714 | Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. | Am J Med | 1998 |
| 9576570 | Serum percent-free PSA does not predict extraprostatic spread of prostate cancer. | Am J Clin Pathol | 1998 |
| 9836538 | Reference ranges for serum prostate-specific antigen in black and white men without cancer. | Urology | 1998 |
| 9697778 | Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. | Urology | 1998 |
| 9000179 | Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system. | Urology | 1997 |
| 12735828 | Enhancing PSA performance in the diagnosis of prostate cancer. | Can J Urol | 1997 |
| 9127226 | Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians. | J Gen Intern Med | 1997 |
| 9224330 | A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer. | J Urol | 1997 |
| 9126236 | Using prostate-specific antigen to eliminate the staging radionuclide bone scan. | Urol Clin North Am | 1997 |
| 9126235 | Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer. | Urol Clin North Am | 1997 |
| 9126233 | Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigen. | Urol Clin North Am | 1997 |
| 9126232 | Age-specific reference ranges for serum prostate-specific antigen. | Urol Clin North Am | 1997 |
| 9126230 | Prostate-specific antigen density. | Urol Clin North Am | 1997 |
| 9126225 | The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration. | Urol Clin North Am | 1997 |
| 9218012 | Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. The Finasteride PSA Study Group. | Urology | 1997 |
| 9121181 | Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer. | Mayo Clin Proc | 1997 |
| 9214675 | Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. | J Natl Cancer Inst | 1997 |
| 9258062 | Update on the appropriate staging evaluation for newly diagnosed prostate cancer. | J Urol | 1997 |
| 9161345 | The decision to seek care. Factors associated with the propensity to seek care in a community-based cohort of men. | Arch Fam Med | 1997 |
| 9111627 | Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary? | Urology | 1997 |
| 9111615 | Analysis and presentation. Clinical trials on prostate cancer. | Urology | 1997 |
| 9145716 | Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. | JAMA | 1997 |
| 9186314 | The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. | J Urol | 1997 |
| 11066505 | Medical malpractice implications of PSA testing for early detection of prostate cancer. | J Law Med Ethics | 1997 |
| 9436284 | Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy. | World J Urol | 1997 |
| 9338731 | Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-month placebo-controlled study with terazosin. HYCAT Investigator Group. Hytrin Community Assessment Trial. | Urology | 1997 |
| 7490873 | The effect of finasteride on prostate specific antigen: review of available data. | J Urol | 1996 |
| 12118563 | Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. | Int J Radiat Oncol Biol Phys | 1996 |
| 8973706 | In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples. | Urology | 1996 |
| 8973699 | Multicenter comparison of the diagnostic performance of free prostate-specific antigen. | Urology | 1996 |
| 8973698 | Half-life determination of serum free prostate-specific antigen following radical retropubic prostatectomy. | Urology | 1996 |
| 8973692 | The clinical usefulness of percent free-PSA. | Urology | 1996 |
| 8973671 | Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer. | Urology | 1996 |
| 8905498 | Interpreting results of prostate-specific antigen testing for early detection of prostate cancer. | J Gen Intern Med | 1996 |
| 8944739 | Predictive properties of serum-prostate-specific antigen testing in a community-based setting. | Arch Intern Med | 1996 |
| 8753736 | Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate. | Urology | 1996 |
| 8753735 | Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. | Urology | 1996 |
| 8886054 | Recommendations of the first Michigan conference on prostate cancer. | Urology | 1996 |